AI Eye Scan: Rapid Diagnosis with AI
- Acer Medical is revolutionizing eye lesion detection with its artificial intelligence-assisted diagnostic software.
- Traditionally, diagnosing these conditions could take weeks, ofen involving multiple specialists.
- The AI-driven approach uses VeriSee DR for diabetic retinopathy and VeriSee AMD for age-related macular degeneration.
Acer Medical’s AI is fast-tracking eye care, revolutionizing eye lesion detection with its cutting-edge AI-assisted diagnostic software. Diagnosis times have been slashed from weeks to mere seconds, a remarkable feat in healthcare. The system utilizes high-resolution fundus photography coupled with AI algorithms, streamlining the process and making early disease detection, particularly for conditions like diabetic retinopathy, more efficient. Acer Medical’s innovation, running on Intel-backed AI PCs, processes data locally, making it perfect for remote healthcare settings. News Directory 3 is following the latest developments and the impact on patient care. Discover the future and how this technology will change healthcare access for all.
AI-Powered Eye Scan Slashes Diagnosis Time for Eye Lesions
Updated June 13, 2025
Acer Medical is revolutionizing eye lesion detection with its artificial intelligence-assisted diagnostic software. The Taiwan-based company, an Acer group subsidiary, combines its software with intel hardware to deliver results in seconds, according to an official statement. This advancement marks a meaningful leap in healthcare, particularly in diagnosing conditions like diabetic retinopathy and age-related macular degeneration.
Traditionally, diagnosing these conditions could take weeks, ofen involving multiple specialists. now, acer Medical’s AI-assisted diagnostic software, running on Intel-backed AI PCs, provides results almost instantly. The system uses high-resolution fundus photography to scan the inner eye, with AI algorithms analyzing the images. This eliminates the need for dilation and long wait times. The AI PC processes everything locally,making it ideal for remote healthcare settings.
The AI-driven approach uses VeriSee DR for diabetic retinopathy and VeriSee AMD for age-related macular degeneration. Developed in partnership with medical specialists, the technology is available in 13 countries. Dr. Hsieh Yi-Ting, a retina specialist at National Taiwan University Hospital, played a key role in developing these solutions.
Acer Medical specializes in AI-driven medical diagnostics, focusing on leveraging artificial intelligence, clinical data, and software growth to create healthcare solutions. Their technology has been implemented in over 300 hospitals and clinics, serving an estimated 450,000 patients annually.Their AI-powered tools, like VeriSee DR and VeriSee AMD, help detect eye diseases such as diabetic retinopathy and age-related macular degeneration in seconds, considerably reducing diagnosis time.
Dr. hsieh Yi-Ting developed the VeriSee DR and VeriSee AMD solutions, which are now available in 13 countries. These tools help doctors prioritize cases and expedite treatment, but they don’t replace medical professionals—rather, they enhance their ability to provide faster, more accurate care.
What’s next
This AI-driven approach is poised to transform rural healthcare, enabling specialists to diagnose patients remotely. The expansion of AI in medicine promises faster, more accessible healthcare solutions for underserved populations.